Genistein, a well-documented natural chemopreventive agent, directly downregulates the MDM2 oncogene, by reducing the levels of MDM2 mRNA and protein in several tested human cell lines, including cancers of the breast, colon, and prostate, and normal cell lines, such as primary fibroblasts and breast epithelial cells. The gene discussed is MDM2; the disease is medical procedure.